<DOC>
	<DOCNO>NCT01330810</DOCNO>
	<brief_summary>Each year , 150,000 new colorectal cancer ( CRC ) case 50,000 CRC death United States . A safe effective preventive agent could reduce burden colorectal cancer well reduce cost associated screen patient high risk develop CRC . Preclinical study strongly suggest curcumin active multiple pathway implicate tumor initiation , progression , metastasis . However , little know curcumin performs human . The investigator propose enroll 12 healthy volunteer undergo blood draw rectal biopsy 7 day curcumin administration . The investigator look curcumin preparation low high oral bioavailability calculate blood rectal tissue concentration associate two formulation determine preparation produce high tissue concentration .</brief_summary>
	<brief_title>Curcumin Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Curcumin</mesh_term>
	<criteria>1 . 18 65 year age 2 . BMI 18 30 kg/m^2 3 . Ability/willing provide inform consent 4 . Good general health 1 . History pancreatic biliary disease ( eg . Familial colorectal cancer syndrome , Ulcerative colitis Crohn 's disease ) 2 . History acute chronic illness require current medical therapy , include active gastrointestinal condition , might interfere drug absorption 3 . History large bowel resection reason 4 . Diagnosed narcotic alcohol dependence 5 . Women childbearing potential agree practice effective birth control . 6 . Use curcumin within last 14 day 7 . Allergy study agent 8 . Individuals creatinine , AST ALT 1.5 time upper limit normal baseline . 9 . Personal inherit bleed disorder therapeutic anticoagulation warfarin . 10 . Women pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Dietary Supplements</keyword>
	<keyword>Curcumin</keyword>
</DOC>